REVA to Present at 30th Annual J.P. Morgan Healthcare Conference

San Diego, California (Thursday, January 5, 2012 PST) - REVA Medical, Inc. (ASX: RVA) ("REVA" or the "Company") is pleased to announce that its Chairman and CEO, Robert Stockman, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference at 1:30 p.m. US PST on Wednesday, January 11, 2012. The conference is being held January 9 through

12, 2012 at The Westin St. Francis Hotel in San Francisco, California.

A copy of the presentation materials will be available on REVA's website at

www.revamedical.com shortly before the presentation.

About REVA

REVA is a development stage medical device company incorporated in Delaware, USA, that is focused on the development and eventual commercialisation of its proprietary, bioresorbable stent products. REVA's lead product, the ReZolve™ scaffold, combines REVA's proprietary stent design with a proprietary polymer that is metabolized and cleared from the body. The ReZolve scaffold is designed to offer full x-ray visibility, clinically relevant sizing and a controlled and safe resorption rate. In addition, by early encapsulation of the stent in the artery tissue coupled with the loss of scaffold structure over time, the ReZolve scaffold may reduce the incidence of late forming blood clots, or thrombosis, a rare but serious problem associated with drug-eluting metal stents currently on the market. REVA will require clinical results and regulatory approval before it can begin selling the ReZolve scaffold.

United States Investor and Media Enquiries:

Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045

Australia Investor Enquiries:

David Allen or Alan Taylor
Inteq Limited
+61 2 9231 3322

Media Enquiries:

Katie Mackenzie or Rebecca Wilson
Buchan Consulting
+61 3 9866 4722

HEAD OFFICE: 5751 Copley Drive, San Diego, CA 92111 • +1 (858) 966-3000 • +1 (858) 966-3099 (FAX) www.revamedical.com

AUSTRALIAN OFFICE: Level 6, 175 Macquarie Street, Sydney, NSW 2000 • +61 2 9231 3322 • +61 9229 2727 (FAX) ARBN 146 505 777

distribué par

Ce noodl a été diffusé par REVA Medical Inc. et initialement mise en ligne sur le site http://www.teamreva.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-05 23:27:35 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.

Documents associés
REVA to Present at 30th Annual J.P. Morgan Healthcare Conference